Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023
Authors:
- Sandra WitteveenSWSandra Witteveen
- Jörg B HansJHJörg B Hans
- Radosław IzdebskiRIRadosław Izdebski
- Henrik HasmanHHHenrik Hasman
- Ørjan SamuelsenØSØrjan Samuelsen
- Laurent DortetLaurent Dortet
- Jesús Oteo-IglesiasJOJesús Oteo-Iglesias
- Dorota ŻabickaDŻDorota Żabicka
- Martin CormicanMCMartin Cormican
- Mirco SandfortMSMirco Sandfort
Open Access
- 6 June 2024
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (23) , 2300616
Abstract
Background: The war in Ukraine led to migration of Ukrainian people. Early 2022, several European national surveillance systems detected multidrug-resistant (MDR) bacteria related to Ukrainian patients. Aim: To investigate the genomic epidemiology of New Delhi metallo-β-lactamase (NDM)-producing Providencia stuartii from Ukrainian patients among European countries. Methods: Whole-genome sequencing of 66 isolates sampled in 2022–2023 in 10 European countries enabled whole-genome multilocus sequence typing (wgMLST), identification of resistance genes, replicons, and plasmid reconstructions. Five bla NDM-1-carrying-P. stuartii isolates underwent antimicrobial susceptibility testing (AST). Transferability to Escherichia coli of a bla NDM-1-carrying plasmid from a patient strain was assessed. Epidemiological characteristics of patients with NDM-producing P. stuartii were gathered by questionnaire. Results: wgMLST of the 66 isolates revealed two genetic clusters unrelated to Ukraine and three linked to Ukrainian patients. Of these three, two comprised bla NDM-1-carrying-P. stuartii and the third bla NDM-5-carrying-P. stuartii. The bla NDM-1 clusters (PstCluster-001, n = 22 isolates; PstCluster-002, n = 8 isolates) comprised strains from seven and four countries, respectively. The bla NDM-5 cluster (PstCluster-003) included 13 isolates from six countries. PstCluster-001 and PstCluster-002 isolates carried an MDR plasmid harbouring bla NDM-1, bla OXA-10, bla CMY-16, rmtC and armA, which was transferrable in vitro and, for some Ukrainian patients, shared by other Enterobacterales. AST revealed PstCluster-001 isolates to be extensively drug-resistant (XDR), but susceptible to cefiderocol and aztreonam–avibactam. Patients with data on age (n = 41) were 19–74 years old; of 49 with information on sex, 38 were male. Conclusion: XDR P. stuartii were introduced into European countries, requiring increased awareness and precautions when treating patients from conflict-affected areas.Keywords
This publication has 18 references indexed in Scilit:
- Genomic Analysis of two NDM-1 Providencia stuartii Strains Recovered from a Single PatientCurrent Microbiology, 2020
- Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, FranceJournal of Antimicrobial Chemotherapy, 2020
- Dissemination of NDM-1 carbapenemase-producer Providencia stuartii strains in Romanian hospitals: a multicentre studyJournal of Hospital Infection, 2019
- First literature review of carbapenem-resistant ProvidenciaNew Microbes and New Infections, 2018
- Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin ( bla SHV-5 , bla VEB-1 ), Carbapenem ( bla VIM-1 ), and Aminoglycoside ( rmtB ) Resistance Determinants by a Multidrug-Resistant Outbreak CloneMicrobial Drug Resistance, 2016
- Draft Genome Sequence of the First NDM-1-Producing Providencia stuartii Strain Isolated in PortugalMicrobiology Resource Announcements, 2015
- Nosocomial dissemination of Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospitalJournal of Antimicrobial Chemotherapy, 2012
- Outbreak of Carbapenem-Resistant Providencia stuartii in an Intensive Care UnitInfection Control & Hospital Epidemiology, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- A General Method for Detecting and Sizing Large PlasmidsAnalytical Biochemistry, 1995